248 related articles for article (PubMed ID: 1153992)
1. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
[TBL] [Abstract][Full Text] [Related]
2. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
[TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
[TBL] [Abstract][Full Text] [Related]
4. [Method for diphenylhydantoin and phenobarbital assay by gas chromatography].
Khodjet el Khil R; Batt AM; Siest G; Tridon P; Weber M
Pathol Biol (Paris); 1975 May; 23(5):409-16. PubMed ID: 1105335
[TBL] [Abstract][Full Text] [Related]
5. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
Borst SI; Lockwood CH
Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
[TBL] [Abstract][Full Text] [Related]
6. [Phenytoin intoxication and serum level].
Beier R; Zschiesche M; Cammann R
Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):414-23. PubMed ID: 704704
[TBL] [Abstract][Full Text] [Related]
7. [Value of anticonvulsant level determination in the treatment of epilepsies].
Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
[TBL] [Abstract][Full Text] [Related]
8. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of antiepileptic drugs.
Shakya G; Malla S; Shakya KN; Shrestha R
JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of phenobarbital and phenytoin in epileptic outpatients.
Driessen O; Höppener R
Eur Neurol; 1977; 15(3):135-42. PubMed ID: 852469
[TBL] [Abstract][Full Text] [Related]
11. Treatment of epilepsy in the light of determinations of the blood levels of anticonvulsants.
Majkowski J
Pol Med J; 1972; 11(1):202-7. PubMed ID: 5040998
[No Abstract] [Full Text] [Related]
12. [Blood levels of phenytoin and phenobarbital in epileptics treated with phenydantin and phenytoinum].
Rosnowska M; Zieliński JJ; Szukalski B
Neurol Neurochir Pol; 1978; 12(5):569-73. PubMed ID: 724029
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of drug therapy in epileptic children.
Singh LM; Mehta S; Vohra RM; Nain CK
Int J Clin Pharmacol Ther Toxicol; 1987 May; 25(5):251-4. PubMed ID: 3596850
[TBL] [Abstract][Full Text] [Related]
14. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
Buchanan RA; Allen RJ
Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
[No Abstract] [Full Text] [Related]
15. The necessity of drug level monitoring in anticonvulsant drug therapy.
Davis HL; Bailey DG; Johnson GE; Wilson TW
Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
[TBL] [Abstract][Full Text] [Related]
16. Decrease in serum diphenylhydantoin levels after withdrawal of phenobarbital in epileptics treated with both drugs.
Arakawa T; Yoshida T; Tanabu M; Karahashi M; Takagi T
Tohoku J Exp Med; 1974 Feb; 112(2):165-8. PubMed ID: 4836028
[No Abstract] [Full Text] [Related]
17. [Consequeces of the elimination of a combination drug. Transition from combination antisacer: attention].
de Crousaz G; Schelling JL
Schweiz Med Wochenschr; 1977 Dec; 107(51):1932-6. PubMed ID: 594737
[TBL] [Abstract][Full Text] [Related]
18. The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
Eadie MJ; Lander CM; Hooper WD; Tyrer JH
Proc Aust Assoc Neurol; 1976; 13():89-96. PubMed ID: 1029012
[TBL] [Abstract][Full Text] [Related]
19. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
Vajda FJ; Merory J; Bladin PF
Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of plasma diphenylhydantoin levels in epileptic patients].
Lezama-Dávila CM; Olmos-García de Alba G; López-Anaya A; Valarezo-Crespo F
Bol Med Hosp Infant Mex; 1983 May; 40(5):256-61. PubMed ID: 6871012
[No Abstract] [Full Text] [Related]
[Next] [New Search]
